ACCRA (Citi Newsroom) –
Yemaachi Biotechnology, Africa’s Cancer Research Company has introduced the Sheba HPV Test, an effective home sampling kit to test for high-risk Human Papillomavirus (HPV) which is responsible for 99% of cervical cancer cases.
The Sheba HPV Test is an innovative product that identifies women who are at high risk for cervical cancer, which is currently the second most prevalent cancer in Ghanaian women, killing approximately 2000 every year. However, when detected early, cervical cancer is highly successfully treatable.